These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16009172

  • 1. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
    Denschlag D, Bettendorf H, Watermann D, Keck C, Tempfer C, Pietrowski D.
    Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma.
    Hsieh YY, Wang JP, Lin CS.
    Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536
    [Abstract] [Full Text] [Related]

  • 4. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
    Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA, Girão MJ, Nishimura E, Baracat EC, Silva ID.
    Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population.
    Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH, Maruo T.
    J Soc Gynecol Investig; 2004 May; 11(4):232-6. PubMed ID: 15120697
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The p21 codon 31*C- and DRD2 codon 313*T-related genotypes/alleles, but not XRCC1 codon 399, hOGG1 codon 326, and DRD1-48 polymorphisms, are correlated with the presence of leiomyoma.
    Hsieh YY, Chang CC, Bau DT, Tsai FJ, Tsai CH, Chen CP.
    Fertil Steril; 2009 Mar; 91(3):869-77. PubMed ID: 19176223
    [Abstract] [Full Text] [Related]

  • 10. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P, Sengupta S.
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk.
    Renner SP, Strick R, Fasching PA, Oeser S, Oppelt P, Mueller A, Beckmann MW, Strissel PL.
    Am J Obstet Gynecol; 2008 Dec; 199(6):648.e1-9. PubMed ID: 18691687
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
    Litovkin KV, Domenyuk VP, Bubnov VV, Zaporozhan VN.
    Exp Oncol; 2007 Dec; 29(4):295-8. PubMed ID: 18199986
    [Abstract] [Full Text] [Related]

  • 14. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
    El-Shennawy GA, Elbialy AA, Isamil AE, El Behery MM.
    Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
    [Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Takemura N, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T.
    J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
    [Abstract] [Full Text] [Related]

  • 16. Germline polymorphism of p53 codon 72 in gynecological cancer.
    Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Yamaguchi H, Nishiyama K, Yasuda M, Ueki M.
    Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
    [Abstract] [Full Text] [Related]

  • 17. COX2 and p53 risk-alleles coexist in COPD.
    Arif E, Vibhuti A, Deepak D, Singh B, Siddiqui MS, Pasha MA.
    Clin Chim Acta; 2008 Nov; 397(1-2):48-50. PubMed ID: 18692035
    [Abstract] [Full Text] [Related]

  • 18. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
    Govan VA, Loubser S, Saleh D, Hoffman M, Williamson AL.
    Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
    [Abstract] [Full Text] [Related]

  • 19. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y.
    Clin Cancer Res; 2005 Oct 15; 11(20):7328-33. PubMed ID: 16243804
    [Abstract] [Full Text] [Related]

  • 20. X-ray repair cross-complementing group 4 (XRCC4) promoter -1394( *)T-related genotype, but not XRCC4 codon 247/intron 3 or xeroderma pigmentosum group D codon 312, 751/promoter -114, polymorphisms are correlated with higher susceptibility to myoma.
    Hsieh YY, Chang CC, Bau DT, Yeh LS, Tsai FJ, Tsai CH.
    Fertil Steril; 2008 Oct 15; 90(4 Suppl):1417-23. PubMed ID: 18177646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.